Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
India
Pharma
TROP2 showdown, InnoCare-Zenas, Lupin—Fierce Pharma Asia
AZ and Daiichi reported a positive phase 3 trial in TNBC. InnoCare and Zenas signed a potential $2 billion deal. Lupin will build a new U.S. plant.
Angus Liuu
Oct 10, 2025 10:55am
Lilly earmarks $1B-plus for contract manufacturing in India
Oct 6, 2025 11:32am
Sun plant placed on FDA import alert over contamination issues
Sep 11, 2025 9:25am
Novartis-Argo, Eisai, Henlius—Fierce Pharma Asia
Sep 5, 2025 9:00am
AstraZeneca cancels Indian manufacturing license
Sep 3, 2025 12:00pm
Padcev-Keytruda result, Alzheimer's med, Fosun—Fierce Pharma Asia
Aug 15, 2025 8:31am
